This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04613/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04613/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04613/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04613/identifier/pdb/

Statements

Subject Item
n2:DB04613
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB04613 n11:DB04613
dcterms:title
(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER
adms:identifier
n9:9IN n10:5287569 n12:DB04613 n13:46506597
n3:IUPAC-Name
n4:271B4344-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B434A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4349-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4346-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4347-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4348-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4342-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4340-363D-11E5-9242-09173F13E4C5 n4:271B4343-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4341-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4350-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4351-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B434B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B434C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B434E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B434D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B434F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4356-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4358-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4359-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4355-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4354-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4357-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4345-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4352-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4353-363D-11E5-9242-09173F13E4C5